Article
CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration
2023-08-02
Abstract excerpt
<h4>Background: </h4> Immunomodulatory (IM) subtype triple negative breast cancer (TNBC) has high immune cell signaling, cytokine signaling gene expression, and is more responsive to immunotherapy. The mechanism responsible for this phenomenon is not clear, but the gene, the cytotoxic and regulatory T cell molecule (CRTAM), seems to be involved in this process. Methods A total of 360 TNBC patients diagnosed with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5371f49c-7597-525d-be5b-7ffe1038dfa8
- DOI
- 10.21203/rs.3.rs-3208041/v1
